SomnoMed (ASX:SOM) Short-Term Capital Lease Obligation : A$0.00 Mil (As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is SomnoMed Short-Term Capital Lease Obligation?

SomnoMed's Short-Term Capital Lease Obligation for the quarter that ended in Dec. 2023 was A$0.00 Mil.

SomnoMed's quarterly Short-Term Capital Lease Obligation increased from Dec. 2022 (A$0.00 Mil) to Jun. 2023 (A$2.26 Mil) but then declined from Jun. 2023 (A$2.26 Mil) to Dec. 2023 (A$0.00 Mil).

SomnoMed's annual Short-Term Capital Lease Obligation declined from Jun. 2021 (A$1.96 Mil) to Jun. 2022 (A$1.78 Mil) but then increased from Jun. 2022 (A$1.78 Mil) to Jun. 2023 (A$2.26 Mil).

SomnoMed Short-Term Capital Lease Obligation Historical Data

The historical data trend for SomnoMed's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SomnoMed Short-Term Capital Lease Obligation Chart

SomnoMed Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.23

2.33

1.96

1.78

2.26

SomnoMed Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															-	1.78	-	2.26	-

SomnoMed Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

SomnoMed Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of SomnoMed's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

SomnoMed (ASX:SOM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SomnoMed Ltd (ASX:SOM) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

SOMNF:USA RJV:Germany

Address

20 Clarke Street, Level 3, Crows Nest, Sydney, NSW, AUS, 2065

Website

https://www.somnomed.com/au

SomnoMed Ltd produces and sells oral treatment of sleep-related disorder devices. It manufactures and designs premium oral appliances for the treatment of sleep-disordered breathing relieving conditions. Its products include SomnoDent, Som Tabs, Som Morning Repositioner and others. Its geographical segments include North America, Europe, and Asia-Pacific. Business operations consist of the production and sale of products treating sleep-disordered breathing, which is the only reportable segment. Substantial revenue is realized from the European region.

SomnoMed (ASX:SOM) Headlines

No Headlines